Sign up to save your podcasts
Or
Share Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Improving Treatment Outcomes: Advancing Adjuvant Therapy for Early ER+ Breast Cancer
Dr Erica Mayer is the director of clinical research and institute physician at the Breast Oncology Centre, Dana-Faber Cancer Institute, and associate professor of medicine at Harvard Medical School in Boston, United States.
Dr Mayer's research focuses on the role of novel therapies in the treatment of breast cancer and we spoke with her about improving efficacy in the adjuvant treatment of early ER+ breast cancer.
View all episodes
By Breast Cancer TrialsDr Erica Mayer is the director of clinical research and institute physician at the Breast Oncology Centre, Dana-Faber Cancer Institute, and associate professor of medicine at Harvard Medical School in Boston, United States.
Dr Mayer's research focuses on the role of novel therapies in the treatment of breast cancer and we spoke with her about improving efficacy in the adjuvant treatment of early ER+ breast cancer.